Secondly, while APCand TP53 mutation rates were significantly lower in RCC patientsthan in LCC patients, KRAS, SYNE1, andMUC16 mutation rates were instead significantly higher. Here, KRAS is linked to leukoencephalopathy with calcifications and cysts.